The association between antidepressant use and deaths from road traffic accidents: a case-crossover study.
Antidepressants
Case-crossover design
Pharmacoepidemiology
Traffic accidents
Journal
Social psychiatry and psychiatric epidemiology
ISSN: 1433-9285
Titre abrégé: Soc Psychiatry Psychiatr Epidemiol
Pays: Germany
ID NLM: 8804358
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
04
06
2018
accepted:
17
11
2018
pubmed:
27
11
2018
medline:
24
5
2019
entrez:
27
11
2018
Statut:
ppublish
Résumé
Antidepressants are some of the most commonly used psychiatric medications, but little information is available about the effects of antidepressant treatment on the risk of traffic accidents across classes of antidepressants or associated with each substance individually. To investigate the relationship between exposure to antidepressants and risk of fatality in road traffic accidents. We used a Korean national road traffic authority database linked with a national health insurance database between January 1, 2010 and December 31, 2014 and applied a case-crossover design. The study subjects were drivers in South Korea who died from traffic accidents and who had prescriptions for antidepressants within 1 year prior to the date of the accident. We compared the status of prescription for antidepressants with the hazard period and four matched control periods using conditional logistic regression, adjusting for other drug use. The trends of antidepressant utilization were described in terms of the number of prescriptions. A case-case-time-control design was applied to drugs with an increasing trend in use and a significant case-crossover odds ratio (OR). A total of 1250 antidepressant-using drivers were included, and an increased risk was observed during the 30-day hazard period (adjusted OR 1.30; 95% CI 1.03-1.63). Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) showed significant risks, but tricyclic antidepressants did not. However, the associations of all antidepressants, SSRIs, SNRIs, escitalopram, and duloxetine did not remain significant after adjusting for trends in utilization. Paroxetine and milnacipran were associated with increased risks, with no obvious increase in their utilization, but the possibility of confounding by indication could have affected the results for milnacipran. Considering the trends of antidepressant prescription and utilization, the use of paroxetine increased the risk of fatal traffic accidents.
Identifiants
pubmed: 30474691
doi: 10.1007/s00127-018-1637-4
pii: 10.1007/s00127-018-1637-4
doi:
Substances chimiques
Antidepressive Agents
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
485-495Subventions
Organisme : Ministry of Land, Infrastructure and Transport in Korea
ID : 14TLRP-B085437-01
Références
Arch Gen Psychiatry. 1999 Oct;56(10):897-904
pubmed: 10530631
Br J Clin Pharmacol. 2000 Feb;49(2):118-25
pubmed: 10671905
J Clin Psychiatry. 2000 Apr;61(4):268-75
pubmed: 10830147
Annu Rev Public Health. 2000;21:193-221
pubmed: 10884952
Int Clin Psychopharmacol. 2000 Nov;15(6):305-18
pubmed: 11110006
J Psychopharmacol. 2002 Sep;16(3):207-14
pubmed: 12236626
Hum Psychopharmacol. 2003 Jun;18(4):261-9
pubmed: 12766930
Am J Epidemiol. 1992 Oct 1;136(7):873-83
pubmed: 1442753
Hum Psychopharmacol. 2004 Jan;19(1):1-7
pubmed: 14716705
Pharmacoepidemiol Drug Saf. 1997 Oct;6 Suppl 3:S51-9
pubmed: 15073755
Br J Psychiatry. 2004 May;184:386-92
pubmed: 15123501
MedGenMed. 2005 Jul 06;7(3):22
pubmed: 16369248
Eur J Clin Pharmacol. 2006 Sep;62(9):757-64
pubmed: 16802165
Psychopharmacology (Berl). 2006 Sep;188(1):84-91
pubmed: 16865389
Eur J Clin Pharmacol. 2007 Aug;63(8):725-31
pubmed: 17554532
Hum Psychopharmacol. 2008 Jul;23(5):399-407
pubmed: 18383000
J Clin Psychiatry. 2008 Jul;69(7):1099-103
pubmed: 18588362
J Am Geriatr Soc. 2008 Oct;56(10):1968-70
pubmed: 19054208
Am J Epidemiol. 1991 Jan 15;133(2):144-53
pubmed: 1985444
Psychiatry (Edgmont). 2009 Sep;6(9):13-6
pubmed: 19855856
Accid Anal Prev. 2010 Jan;42(1):261-8
pubmed: 19887166
Drug Saf. 2011 Feb 1;34(2):125-56
pubmed: 21247221
Br J Clin Pharmacol. 2011 Sep;72(3):505-13
pubmed: 21501214
Am J Geriatr Psychiatry. 2011 Dec;19(12):998-1006
pubmed: 22123273
J Clin Psychiatry. 2012 Aug;73(8):1088-94
pubmed: 22967773
PLoS One. 2013 Sep 09;8(9):e73973
pubmed: 24040131
BMJ Open. 2013 Sep 19;3(9):e003247
pubmed: 24056479
Br J Clin Pharmacol. 2013 Nov;76(5):810-5
pubmed: 24148104
J Korean Med Sci. 2014 Apr;29(4):468-84
pubmed: 24753693
Int J Psychiatry Clin Pract. 2004;8(2):109-15
pubmed: 24926843
J Am Geriatr Soc. 2015 Nov;63(11):2227-46
pubmed: 26446832
Neurol Ther. 2015 Jun;4(1):39-51
pubmed: 26847674
Inj Prev. 2017 Oct;23(5):356
pubmed: 27597402
Int J Epidemiol. 2017 Jun 1;46(3):799-800
pubmed: 27794523
J Psychiatr Res. 2017 Nov;94:7-14
pubmed: 28628885
Epidemiology. 1994 Nov;5(6):591-8
pubmed: 7841240
Accid Anal Prev. 1994 Apr;26(2):243-7
pubmed: 8198693
Arch Gen Psychiatry. 1994 Jan;51(1):8-19
pubmed: 8279933
Lancet. 1998 Oct 24;352(9137):1331-6
pubmed: 9802269